Summary of Study ST003701
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR002297. The data can be accessed directly via it's Project DOI: 10.21228/M8QG07 This work is supported by NIH grant, U2C- DK119886. See: https://www.metabolomicsworkbench.org/about/howtocite.php
| Study ID | ST003701 |
| Study Title | Targeted metabolomics investigating the role of aconitate decarboxylase 1 during colitis |
| Study Summary | We performed targeted metabolomics on flash frozen colon pieces from naive, Citrobacter rodentium-infected, and DSS-treated WT and Acod1 deficient animals. |
| Institute | Vanderbilt University |
| Last Name | McNamara |
| First Name | Kara |
| Address | 2215 Garland Ave, Nashville, TN 37232 |
| kara.mcnamara@vanderbilt.edu | |
| Phone | 5087333664 |
| Submit Date | 2025-01-17 |
| Raw Data Available | Yes |
| Raw Data File Type(s) | mzML |
| Analysis Type Detail | LC-MS |
| Release Date | 2026-01-02 |
| Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
| Project ID: | PR002297 |
| Project DOI: | doi: 10.21228/M8QG07 |
| Project Title: | Aconitate decarboxylase 1 mediates inflammation in colitis and maintains homeostasis of the metabolome and microbiome |
| Project Summary: | Background & Aims: Aconitate decarboxylase 1 (ACOD1) is implicated in innate immunity and inflammatory responses. We determined the role of ACOD1 in colon inflammation and colitis-associated carcinoma (CAC). Methods: Human inflammatory bowel disease transcriptomic datasets and banked RNA samples were interrogated. C57BL/6 wild-type (WT) and Acod1–/– mice were infected with Citrobacter rodentium or given one or two cycles of 4% dextran sulfate sodium (DSS) as models of colitis. For CAC, mice were given 12.5 mg/kg azoxymethane (AOM) followed by 3 cycles of 4% DSS. Clinical and histological parameters were assessed. Tissues and stool were used for metabolomic and 16S microbiome analyses, respectively. Results: ACOD1 expression is increased in ulcerative colitis (UC) and Crohn’s disease (CD) tissues compared to controls. C. rodentium infection caused body weight loss only in Acod1–/– mice, which had increased histologic injury versus wild-type. In DSS colitis, we observed decreased colon length and increased histologic injury in Acod1–/– versus wild-type mice. There was an altered metabolome in Acod1–/– versus wild-type colon tissues, and during colitis, purine metabolism was most markedly affected. AOM-DSS-treated Acod1–/– animals exhibited more inflammation and injury but no difference in tumorigenesis. 16S microbiome analysis revealed significant differences in phyla and genera; notably an increase in Bacteroidetes and decrease in Proteobacteria in Acod1–/– mice, indicating a dysbiotic state. Conclusions: While ACOD1 is increased in human inflammatory bowel disease (IBD) tissues, our data indicate that this enzyme has a protective role in acute and chronic experimental colitis and is associated with prevention of intestinal dysbiosis and stabilization of the metabolome. |
| Institute: | Vanderbilt University |
| Last Name: | McNamara |
| First Name: | Kara |
| Address: | 2215 Garland Ave, Nashville, TN 37232 |
| Email: | kara.mcnamara@vanderbilt.edu |
| Phone: | 5087333664 |
Subject:
| Subject ID: | SU003833 |
| Subject Type: | Mammal |
| Subject Species: | Mus musculus |
| Taxonomy ID: | 10090 |
| Genotype Strain: | C57BL/7 WT and Acod1-/- ; Citrobacter rodentium DBS100 |
| Age Or Age Range: | 8-12 weeks |
| Gender: | Male and female |
| Animal Animal Supplier: | C57BL/6 Acod1–/– mice28 were provided by Dr. Edward Sherwood at Vanderbilt University Medical Center |
| Animal Housing: | VA animal facility |
| Animal Light Cycle: | 12 on/ 12 off |
| Animal Feed: | 5L0D chow (LabDiet) |
| Animal Water: | Regular water or water with 4% Dextran sulfate sodium (DSS) (TdB Labs) |
Factors:
Subject type: Mammal; Subject species: Mus musculus (Factor headings shown in green)
| mb_sample_id | local_sample_id | Genotype | Treatment |
|---|---|---|---|
| SA405271 | NEG_S17 | Acod1 | Citrobacter rodentium |
| SA405272 | NEG_S19 | Acod1 | Citrobacter rodentium |
| SA405273 | NEG_S20 | Acod1 | Citrobacter rodentium |
| SA405274 | POS_S20 | Acod1 | Citrobacter rodentium |
| SA405275 | POS_S19 | Acod1 | Citrobacter rodentium |
| SA405276 | POS_S18 | Acod1 | Citrobacter rodentium |
| SA405277 | POS_S17 | Acod1 | Citrobacter rodentium |
| SA405278 | POS_S16 | Acod1 | Citrobacter rodentium |
| SA405279 | NEG_S16 | Acod1 | Citrobacter rodentium |
| SA405280 | NEG_S18 | Acod1 | Citrobacter rodentium |
| SA405281 | NEG_S07 | Acod1 | Control |
| SA405282 | NEG_S06 | Acod1 | Control |
| SA405283 | POS_S10 | Acod1 | Control |
| SA405284 | POS_S09 | Acod1 | Control |
| SA405285 | POS_S08 | Acod1 | Control |
| SA405286 | POS_S07 | Acod1 | Control |
| SA405287 | POS_S06 | Acod1 | Control |
| SA405288 | NEG_S08 | Acod1 | Control |
| SA405289 | NEG_S09 | Acod1 | Control |
| SA405290 | NEG_S10 | Acod1 | Control |
| SA405291 | POS_S27 | Acod1 | Dextran sulfate sodium |
| SA405292 | POS_S30 | Acod1 | Dextran sulfate sodium |
| SA405293 | POS_S29 | Acod1 | Dextran sulfate sodium |
| SA405294 | POS_S28 | Acod1 | Dextran sulfate sodium |
| SA405295 | NEG_S27 | Acod1 | Dextran sulfate sodium |
| SA405296 | POS_S26 | Acod1 | Dextran sulfate sodium |
| SA405297 | NEG_S26 | Acod1 | Dextran sulfate sodium |
| SA405298 | NEG_S28 | Acod1 | Dextran sulfate sodium |
| SA405299 | NEG_S29 | Acod1 | Dextran sulfate sodium |
| SA405300 | NEG_S30 | Acod1 | Dextran sulfate sodium |
| SA405301 | NEG_S12 | WT | Citrobacter rodentium |
| SA405302 | POS_S15 | WT | Citrobacter rodentium |
| SA405303 | POS_S14 | WT | Citrobacter rodentium |
| SA405304 | POS_S13 | WT | Citrobacter rodentium |
| SA405305 | NEG_S15 | WT | Citrobacter rodentium |
| SA405306 | NEG_S14 | WT | Citrobacter rodentium |
| SA405307 | NEG_S13 | WT | Citrobacter rodentium |
| SA405308 | POS_S12 | WT | Citrobacter rodentium |
| SA405309 | POS_S11 | WT | Citrobacter rodentium |
| SA405310 | NEG_S11 | WT | Citrobacter rodentium |
| SA405311 | POS_S01 | WT | Control |
| SA405312 | NEG_S05 | WT | Control |
| SA405313 | NEG_S04 | WT | Control |
| SA405314 | POS_S03 | WT | Control |
| SA405315 | POS_S04 | WT | Control |
| SA405316 | POS_S05 | WT | Control |
| SA405317 | NEG_S01 | WT | Control |
| SA405318 | NEG_S02 | WT | Control |
| SA405319 | POS_S02 | WT | Control |
| SA405320 | NEG_S03 | WT | Control |
| SA405321 | POS_S24 | WT | Dextran sulfate sodium |
| SA405322 | POS_S23 | WT | Dextran sulfate sodium |
| SA405323 | NEG_S21 | WT | Dextran sulfate sodium |
| SA405324 | POS_S25 | WT | Dextran sulfate sodium |
| SA405325 | NEG_S23 | WT | Dextran sulfate sodium |
| SA405326 | NEG_S24 | WT | Dextran sulfate sodium |
| SA405327 | NEG_S25 | WT | Dextran sulfate sodium |
| SA405328 | POS_S22 | WT | Dextran sulfate sodium |
| SA405329 | POS_S21 | WT | Dextran sulfate sodium |
| SA405330 | NEG_S22 | WT | Dextran sulfate sodium |
| Showing results 1 to 60 of 60 |
Collection:
| Collection ID: | CO003826 |
| Collection Summary: | Flash frozen colonic tissues from C. rodentium-infected or DSS-treated WT and Acod1–/– animals were subjected to untargeted metabolomic analysis. |
| Sample Type: | Colon |
| Storage Conditions: | Described in summary |
Treatment:
| Treatment ID: | TR003842 |
| Treatment Summary: | Mice were inoculated with a single sublethal dose of 5 x 108 C. rodentium DBS100 via oral gavage. Control mice received sterile Luria-Bertani broth. Animals were monitored and weighed daily for 14 days. At day 14, mice were sacrificed, and the colons were removed, measured, cleaned, and weighed. Proximal and distal pieces of colon were collectedand flash frozen for metabolomic analysis. In the acute model of DSS-induced colitis, WT and Acod1–/– mice were treated with 4% DSS (TdB Labs) in their drinking water for 5 days before the DSS was removed and replaced with regular water for an additional 5 days. At day 10, mice were sacrificed, and the colons were removed, measured, cleaned, and weighed. Proximal and distal pieces of colon were collectedand flash frozen for metabolomic analysis. |
| Treatment Dose: | 5 x 108 C. rodentium and 4% DSS |
| Treatment Doseduration: | 14 days for bacteria and 5 days of DSS |
| Animal Endp Euthanasia: | 14 days and 10 days |
Sample Preparation:
| Sampleprep ID: | SP003840 |
| Sampleprep Summary: | Lipid extraction and tandem mass spectrometry: To evaluate differences in hepatic lipid metabolism tandem mass spectrometry of extracted lipids was performed. For this purpose, 10 mg liver tissue was homogenized in 500 μL ddH2O on ice. Then, 50 μL of the homogenate was transferred into a fresh Eppendorf tube and 500 μL Extraction Mix (CHCl3/MeOH 1/5 containing the following internal standards: 210 pmol PE(31:1), 396 pmol PC(31:1), 98 pmol PS(31:1), 84 pmol PI(34:0), 56 pmol PA(31:1), 51 pmol PG (28:0), 28 pmol CL(56:0), 39 pmol LPA (17:0), 35 pmol LPC(17:1), 38 pmol LPE (17:0), 32 pmol Cer(17:0), 99 pmol, SM(17:0), 55 pmol GlcCer(12:0), 14 pmol GM3 (18:0-D3), 339 pmol TG(50:1-d4), 111 pmol, CE(17:1), 64 pmol DG(31:1), 103 pmol MG(17:1), 724 pmol Chol(d6) and 45 pmol Car(15:0) was added. After 2 min of sonication in a bath sonicator, the samples were spun at 20,000 g for 2 min. The supernatant was collected in a new Eppendorf tube and 200 μL chloroform and 750 μL of 1 M Ammonium acetate (NH4Ac) in ddH2O were added. Following quick manual shaking, the samples were centrifuged at 20,000 g for 2 min again. The upper phase was carefully removed, and the lower phase was transferred into a new Eppendorf tube. The solvent was evaporated using a SpeedVac Vacuum Concentrator at 45 °C for 20 min. The dried lipids were dissolved in 500 μL Spray Buffer (Isopropanol, Methanol, ddH2O (all MS grade), 10 mM ammonium acetate, 0.1 % acetic acid by sonication for 5 min. Until measurement with a Thermo Q Exactive ™ Plus (Thermo Scientific) using positive mode, the samples were stored at -20 °C. Before the acquisition, the samples were sonicated for 5 min. |
Combined analysis:
| Analysis ID | AN006072 | AN006073 |
|---|---|---|
| Chromatography ID | CH004612 | CH004612 |
| MS ID | MS005779 | MS005780 |
| Analysis type | MS | MS |
| Chromatography type | HILIC | HILIC |
| Chromatography system | Waters Acquity | Waters Acquity |
| Column | Merck Zic-cHILIC analytical (150 x 2.1mm, 3um) | Merck Zic-cHILIC analytical (150 x 2.1mm, 3um) |
| MS Type | ESI | ESI |
| MS instrument type | Triple quadrupole | Triple quadrupole |
| MS instrument name | Thermo TSQ Quantum Ultra | Thermo TSQ Quantum Ultra |
| Ion Mode | POSITIVE | NEGATIVE |
| Units | Normalized peak area | Normalized peak area |
Chromatography:
| Chromatography ID: | CH004612 |
| Chromatography Summary: | HILIC-LC. Solvent A: 0.2 % acetic acid and 15 mM ammonium acetate in H2O/CH3CN (9:1); Solvent B: 0.2 % acetic acid and 15 mM ammonium acetate in CH3CN/CH3OH/H2O (90:5:5) |
| Instrument Name: | Waters Acquity |
| Column Name: | Merck Zic-cHILIC analytical (150 x 2.1mm, 3um) |
| Column Temperature: | 22 |
| Flow Gradient: | 0min, 85% B; 2min, 85% B; 5min, 30% B; 9min, 30% B; 11min, 85% B; 20min, 85% B |
| Flow Rate: | 0.3mL/min |
| Solvent A: | 90% water/10% acetonitrile; 0.2% acetic acid; 15mM ammonium acetate |
| Solvent B: | 90% acetonitrile/5% methanol/5% water; 0.2% acetic acid; 15mM ammonium acetate |
| Chromatography Type: | HILIC |
MS:
| MS ID: | MS005779 |
| Analysis ID: | AN006072 |
| Instrument Name: | Thermo TSQ Quantum Ultra |
| Instrument Type: | Triple quadrupole |
| MS Type: | ESI |
| MS Comments: | MS acquisition: 20 min; Data processing: Thermo LCQuan |
| Ion Mode: | POSITIVE |
| MS ID: | MS005780 |
| Analysis ID: | AN006073 |
| Instrument Name: | Thermo TSQ Quantum Ultra |
| Instrument Type: | Triple quadrupole |
| MS Type: | ESI |
| MS Comments: | MS acquisition: 20 min; Data processing: Thermo LCQuan |
| Ion Mode: | NEGATIVE |